View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsHEXO 과거 순이익 실적과거 기준 점검 0/6HEXO 의 수입은 연평균 -42.2%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 연평균 9.1%의 비율로 증가했습니다. 매출은 연평균 39.8%의 비율로 증가해 왔습니다.핵심 정보-42.20%순이익 성장률-4.54%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률5.95%매출 성장률39.79%자기자본이익률-191.40%순이익률-220.13%최근 순이익 업데이트30 Apr 2023최근 과거 실적 업데이트Reported Earnings • Jun 16Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: CA$2.68 loss per share (improved from CA$4.69 loss in 3Q 2022). Revenue: CA$21.6m (down 53% from 3Q 2022). Net loss: CA$117.2m (loss narrowed 19% from 3Q 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in the US.공시 • Jun 13HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023HEXO Corp. announced that they will report Q3, 2023 results After-Market on Jun 14, 2023Reported Earnings • Mar 17Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CA$0.017 (up from CA$27.98 loss in 2Q 2022). Revenue: CA$24.2m (down 54% from 2Q 2022). Net income: CA$722.0k (up CA$711.6m from 2Q 2022). Profit margin: 3.0% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Pharmaceuticals industry in the US.Reported Earnings • Dec 15First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: CA$0.094 loss per share (improved from CA$0.47 loss in 1Q 2022). Revenue: CA$35.8m (down 29% from 1Q 2022). Net loss: CA$56.3m (loss narrowed 52% from 1Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in the US.Reported Earnings • Nov 02Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: CA$2.76 loss per share (further deteriorated from CA$0.90 loss in FY 2021). Revenue: CA$191.1m (up 54% from FY 2021). Net loss: CA$1.07b (loss widened CA$958.8m from FY 2021). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) exceeded analyst estimates by 2.8%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Pharmaceuticals industry in the US.Reported Earnings • Mar 19Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: CA$2.00 loss per share (down from CA$0.17 loss in 2Q 2021). Revenue: CA$52.8m (up 61% from 2Q 2021). Net loss: CA$710.9m (loss widened CA$690.0m from 2Q 2021). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 2,546%. Over the next year, revenue is forecast to grow 61%, compared to a 17% growth forecast for the industry in the US.모든 업데이트 보기Recent updates공시 • Jun 24+ 1 more updateHEXO Corp.(NasdaqCM:HEXO) dropped from NASDAQ Composite IndexHEXO Corp. has been dropped from NASDAQ Composite Index..공시 • Jun 23HEXO Corp. announced that it has received $25 million in fundingOn June 22, 2023, HEXO Corp. closed the transaction. As on the same day, the company has issued 13,500,000 series 1 preferred shares at an issue price of $1 per share for additional gross proceeds to the $13,500,000 in second of two tranches.New Risk • Jun 16New minor risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow. Free cash flow: -CA$48m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-CA$48m). Currently unprofitable and not forecast to become profitable over next 3 years (CA$5.9m net loss in 3 years). Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (US$33.3m market cap).Reported Earnings • Jun 16Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: CA$2.68 loss per share (improved from CA$4.69 loss in 3Q 2022). Revenue: CA$21.6m (down 53% from 3Q 2022). Net loss: CA$117.2m (loss narrowed 19% from 3Q 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in the US.공시 • Jun 13HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023HEXO Corp. announced that they will report Q3, 2023 results After-Market on Jun 14, 2023Reported Earnings • Mar 17Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CA$0.017 (up from CA$27.98 loss in 2Q 2022). Revenue: CA$24.2m (down 54% from 2Q 2022). Net income: CA$722.0k (up CA$711.6m from 2Q 2022). Profit margin: 3.0% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Pharmaceuticals industry in the US.공시 • Feb 09HEXO Corp. Launches Enhanced Inhalation TechnologyHEXO Corp. announced that it will be launching a unique proprietary inhalation technology, intended to greatly improve the cannabis experience. The development allows HEXO to increase its straight edge pre-roll production capacity, accelerating the delivery of the immensely popular Redecan Redees products to include the new TnT cannabis strain series and expanding HEXO’s Original Stash brand to address rising consumer demand. Consumers have reacted positively to the new format and strains, and this expansion supports HEXO’s continued leadership of the Canadian straight edge pre-roll market. The Redecan Redees straight edge pre-roll is HEXO’s premium pre-roll product and Canada’s fastest growing and largest pre-roll in terms of market share. Redees are known as some of the smoothest products on the market and do not have an “after-burn” like many straight edge pre-roll products. Consumers also prefer their ease of use, appealing packaging and convenience over the more common but less consistent commodity cannabis products. Thoughtfully designed with an extra-long filter, tightly packed and offered in a convenient 10-pack, Redecan Redees are the original personal-sized straight edge pre-roll. Redecan Redees straight edge pre-rolls also now feature a unique inhalation technology, developed through comprehensive consumer research and feedback. Incorporating the new proprietary technology allows an enhanced draw and intake, further heightening the consumer experience. HEXO’s flagship Redecan Redees brand is launching several TnT strains throughout the year, including Warlock, Gluberry and Animal Rntz, along with a new 2:1 CBD:THC balanced product, CBD Kush, which offers the benefits of both cannabinoids. The brand will also continue to feature consumer favourites such as the Cold Creek Kush Redees and WappaRedees. HEXO’s Original Stash line will launch its own straight edge pre-rolls, featuring the line’s popular Atomik Sour Haze and Powdered Donuts.공시 • Jan 28HEXO Corp Wins Complete Dismissal of Putative Québec Shareholder Class ActionHEXO Corp. announced that it has won a complete dismissal of the putative securities class action lawsuit pending before the Québec Superior Court against the Company and its former Chief Executive Officer, filed on November 19, 2019 on behalf of certain primary market and secondary market purchasers of securities of the Company. As previously disclosed, HEXO and its former Chief Executive Officer (“Defendants”) were named in a shareholder class action lawsuit filed in the province of Québec. The lawsuit asserted causes of action for misrepresentations and breaches of disclosure obligations under the Québec Securities Act and the Civil Code of Québec in connection with certain statements contained in HEXO’s prospectus, public documents and public oral statements between April 11, 2018 and March 27, 2020. In a 48-page opinion dated January 23, 2023, the Superior Court of Québec dismissed the Plaintiff’s amended motion in its entirety, with costs. The Court agreed with the Defendants that there was “no reasonable possibility” that the secondary market claim filed under the Québec Securities Act had a reasonable chance of success, or that the Plaintiff had demonstrated an arguable case for a primary market class action or a civil liability class action “for misrepresentation under the general principles of fault in the civil law.” The Plaintiff has a right to appeal.공시 • Jan 10HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash BrandsHEXO Corp. announced the launch of its new TnT Cannabis strains under the Redecan and Original Stash Brandslabels across Canada. The new strains further expand HEXO’s top-selling product portfolio and are available on retailer shelves now. The launch includes three new products from HEXO’s popular Redecan line and two new strains under the Original Stash Brand. Redecan’s hang-dried and hand-trimmed cannabis features a trailblazing THC range of 23 to 35% and high terpene profiles tailored for creativity, excitement and to help unwind. The new TnT cannabis strains will feature extremely dense buds covered in trichomes: Sex Panther (flower), an Indica hybrid strain, has a powerful effervescent cake flavour. Violet Fog (flower), a purple reign Indica strain, from the Grape Gasoline and Khalifa Mints Strains features robust fruity and sour notes. Animal Rntz (flower), a combination of Canada’s popular Animal Cookie and California’s RNTZ strains, has a fruity tartness along with a sweet and sour aroma, highlighted by astounding levels of limonene and caryophyllene terpenes. HEXO’sMaster Growers have spent the past two years optimizing cannabis genetics and cultivation techniques on their proprietary Indica and Sativa cannabis strains to maximize terpenes and THC percentages for the Canadian market. The new strains added to the Original Stash Brand line-up leverage Canada’s broadest Licensed Producer’s cultivation capabilities and include: Atomik Sour Haze (flower), Sativa strain features amazing fruity and sour notes. Ghost Gelato (flower), an Indica strain, bringing a funk smell reminiscent of old school marijuana.Reported Earnings • Dec 15First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: CA$0.094 loss per share (improved from CA$0.47 loss in 1Q 2022). Revenue: CA$35.8m (down 29% from 1Q 2022). Net loss: CA$56.3m (loss narrowed 52% from 1Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in the US.공시 • Dec 07HEXO Corp., Annual General Meeting, Jan 31, 2023HEXO Corp., Annual General Meeting, Jan 31, 2023.Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Nov 02Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: CA$2.76 loss per share (further deteriorated from CA$0.90 loss in FY 2021). Revenue: CA$191.1m (up 54% from FY 2021). Net loss: CA$1.07b (loss widened CA$958.8m from FY 2021). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) exceeded analyst estimates by 2.8%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Pharmaceuticals industry in the US.Breakeven Date Change • Nov 01No longer forecast to breakevenThe 9 analysts covering HEXO no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$15.5m in 2025. New consensus forecast suggests the company will make a loss of CA$0 in 2025.Seeking Alpha • Aug 30Hexo to produce Mike Tyson's cannabis brand's products in CanadaHexo (NASDAQ:HEXO) said it signed an exclusive partnership with Mike Tyson's recently formed cannabis company TYSON 2.0. Under the agreement, Hexo will produce TYSON 2.0's products in Canada, including full range of flower, pre-rolls, edibles and vapes. The HEXO-produced lines will launch across Canada in fall 2022, the company said in an Aug. 30 press release. "With their broad product range from flower to straight edge pre-rolls to edibles, the TYSON 2.0 brand fits perfectly into HEXO's market leading portfolio," said Hexo CEO Charlie Bowman. HEXO +4.67% to $0.22 premarket Aug. 30Seeking Alpha • Aug 17Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatterCanopy Growth (NASDAQ:CGC), Tilray Brands (NASDAQ:TLRY), and other Canadian cannabis licensed producers are markedly higher in Wednesday trading as chatter about the industry on WallStreetBets intensifies. In Wednesday morning trading, Canopy (CGC) is up 11%, Tilray (TLRY) up 4%, Aurora Cannabis (NASDAQ:ACB) up 6%, and HEXO Corp. (NASDAQ:HEXO) up 11%. There is increased discussion about Canadian LPs on WallStreetBets which may account for the increases. Tilray (TLRY) CEO Irwin Simon, in a recent interview with Yahoo Finance, said that the U.S. represents in $100B opportunity in cannabis. That opportunity could become reality if a federal marijuana legalization bill gets signed into law. Check out a recent deep dive into Tilray (TLRY) and whether the stock is a buy at this time.Seeking Alpha • Jul 28HEXO receives additional 180 calendar day grace period for regaining complianceHEXO (NASDAQ:HEXO) received an extension of 180 calendar days post expiration of initial 180 calendar days period to regain minimum bid price requirement compliance on July 25, 2022 from the Nasdaq Stock Market. The company now has time until Jan.23, 2023 to regain compliance after which the company is likely to receive notification for shares delisting. The current notification has no impact on the listing.Breakeven Date Change • Jul 21No longer forecast to breakevenThe 9 analysts covering HEXO no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$7.95m in 2024. New consensus forecast suggests the company will make a loss of CA$24.7m in 2024.Board Change • Jul 21High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Seeking Alpha • Jul 05HEXO wins shareholder approval for note transaction with TilrayCanadian cannabis player HEXO Corp (NASDAQ:HEXO) announced on Tuesday that the company’s shareholders voted in favor of its previously disclosed transaction of convertible notes with its domestic rival Tilray (TLRY). ~87% of votes were in favor of approving certain terms of the deal, the company said following a reconvened special meeting of shareholders today. ~18% of the company’s common shares were represented at the meeting, which was initially scheduled for June 14. However, the meeting was adjourned to provide investors more time to evaluate the previously announced amendments to the transaction. Under the deal anticipated to close in 3Q 2022, Tilray (TLRY) is set to purchase as much as $185M of debt Hexo (HEXO) has issued to funds affiliated with HT Investments.Seeking Alpha • Apr 28HEXO: Undervalued, But With Certain Dilution RisksHEXO Corp. runs a consumer packaged goods cannabis business model with a leader position in the Canadian market and a production capacity of 150,000 kgs. HEXO has already signed supply agreements with partners overseas, so I would be expecting an increase in international sales growth in the coming years. In my view, economies of scale, more efficient automated technology, and the integration of new acquisitions will likely lead to lower cost per gram.Breakeven Date Change • Apr 11Forecast to breakeven in 2024The 9 analysts covering HEXO expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 40% per year to 2023. The company is expected to make a profit of CA$7.95m in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule.Board Change • Apr 01High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Mar 19Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: CA$2.00 loss per share (down from CA$0.17 loss in 2Q 2021). Revenue: CA$52.8m (up 61% from 2Q 2021). Net loss: CA$710.9m (loss widened CA$690.0m from 2Q 2021). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 2,546%. Over the next year, revenue is forecast to grow 61%, compared to a 17% growth forecast for the industry in the US.Board Change • Mar 04High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Jan 01High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Chairman of the Board John Bell was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Dec 16First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2022 results: CA$0.47 loss per share (down from CA$0.035 loss in 1Q 2021). Revenue: CA$50.2m (up 70% from 1Q 2021). Net loss: CA$117.3m (loss widened CA$113.1m from 1Q 2021). Revenue missed analyst estimates by 7.2%. Earnings per share (EPS) exceeded analyst estimates by 358%. Earnings per share (EPS) surpassed analyst estimates by 358%. Over the next year, revenue is forecast to grow 76%, compared to a 15% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has fallen by 61% per year, which means it is performing significantly worse than earnings.Seeking Alpha • Dec 14HEXO Q1 Earnings: Not A Great Path ForwardHEXO reported weak FQ1 results for the period ending Oct. 31. The addition of the businesses of Redecan and 48North didn't improve the financials or move the company any closer to being cash flow positive. The stock isn't touchable with the senior debt overhang and another restructuring in the works.Board Change • Dec 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. President, CEO & Director Scott Cooper was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.매출 및 비용 세부 내역HEXO가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NasdaqCM:HEXO 매출, 비용 및 순이익 (CAD Millions)날짜매출순이익일반관리비연구개발비30 Apr 23124-27361131 Jan 23148-30186131 Oct 22177-1,013105331 Jul 22191-1,074122330 Apr 22187-1,042128431 Jan 22164-918109431 Oct 21144-22896431 Jul 21124-11580430 Apr 21112-21475431 Jan 21112-21375431 Oct 2096-49178431 Jul 2081-54691530 Apr 2069-423115731 Jan 2060-411119631 Oct 1956-117114531 Jul 1948-70105330 Apr 1934-3573031 Jan 1922-3054031 Oct 189-3441031 Jul 185-2323030 Apr 184-1215031 Jan 184-2212031 Oct 174-149031 Jul 174-127030 Apr 174-157031 Jan 174-35031 Oct 163-34031 Jul 162-34031 Jul 150-320양질의 수익: HEXO 은(는) 현재 수익성이 없습니다.이익 마진 증가: HEXO는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: HEXO은 수익성이 없으며 지난 5년 동안 손실이 연평균 42.2% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 HEXO의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: HEXO은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(-5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: HEXO는 현재 수익성이 없으므로 자본 수익률이 음수(-191.4%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/06/23 12:58종가2023/06/22 00:00수익2023/04/30연간 수익2022/07/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스HEXO Corp.는 19명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Aaron GreyAlliance Global PartnersDavid KideckelATB CormarkJesse PytlakATB Cormark Historical (Cormark Securities)16명의 분석가 더 보기
Reported Earnings • Jun 16Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: CA$2.68 loss per share (improved from CA$4.69 loss in 3Q 2022). Revenue: CA$21.6m (down 53% from 3Q 2022). Net loss: CA$117.2m (loss narrowed 19% from 3Q 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in the US.
공시 • Jun 13HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023HEXO Corp. announced that they will report Q3, 2023 results After-Market on Jun 14, 2023
Reported Earnings • Mar 17Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CA$0.017 (up from CA$27.98 loss in 2Q 2022). Revenue: CA$24.2m (down 54% from 2Q 2022). Net income: CA$722.0k (up CA$711.6m from 2Q 2022). Profit margin: 3.0% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Pharmaceuticals industry in the US.
Reported Earnings • Dec 15First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: CA$0.094 loss per share (improved from CA$0.47 loss in 1Q 2022). Revenue: CA$35.8m (down 29% from 1Q 2022). Net loss: CA$56.3m (loss narrowed 52% from 1Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in the US.
Reported Earnings • Nov 02Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: CA$2.76 loss per share (further deteriorated from CA$0.90 loss in FY 2021). Revenue: CA$191.1m (up 54% from FY 2021). Net loss: CA$1.07b (loss widened CA$958.8m from FY 2021). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) exceeded analyst estimates by 2.8%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Pharmaceuticals industry in the US.
Reported Earnings • Mar 19Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: CA$2.00 loss per share (down from CA$0.17 loss in 2Q 2021). Revenue: CA$52.8m (up 61% from 2Q 2021). Net loss: CA$710.9m (loss widened CA$690.0m from 2Q 2021). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 2,546%. Over the next year, revenue is forecast to grow 61%, compared to a 17% growth forecast for the industry in the US.
공시 • Jun 24+ 1 more updateHEXO Corp.(NasdaqCM:HEXO) dropped from NASDAQ Composite IndexHEXO Corp. has been dropped from NASDAQ Composite Index..
공시 • Jun 23HEXO Corp. announced that it has received $25 million in fundingOn June 22, 2023, HEXO Corp. closed the transaction. As on the same day, the company has issued 13,500,000 series 1 preferred shares at an issue price of $1 per share for additional gross proceeds to the $13,500,000 in second of two tranches.
New Risk • Jun 16New minor risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow. Free cash flow: -CA$48m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-CA$48m). Currently unprofitable and not forecast to become profitable over next 3 years (CA$5.9m net loss in 3 years). Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (23% increase in shares outstanding). Market cap is less than US$100m (US$33.3m market cap).
Reported Earnings • Jun 16Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: CA$2.68 loss per share (improved from CA$4.69 loss in 3Q 2022). Revenue: CA$21.6m (down 53% from 3Q 2022). Net loss: CA$117.2m (loss narrowed 19% from 3Q 2022). Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Pharmaceuticals industry in the US.
공시 • Jun 13HEXO Corp. to Report Q3, 2023 Results on Jun 14, 2023HEXO Corp. announced that they will report Q3, 2023 results After-Market on Jun 14, 2023
Reported Earnings • Mar 17Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: CA$0.017 (up from CA$27.98 loss in 2Q 2022). Revenue: CA$24.2m (down 54% from 2Q 2022). Net income: CA$722.0k (up CA$711.6m from 2Q 2022). Profit margin: 3.0% (up from net loss in 2Q 2022). Revenue missed analyst estimates by 34%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 7.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Pharmaceuticals industry in the US.
공시 • Feb 09HEXO Corp. Launches Enhanced Inhalation TechnologyHEXO Corp. announced that it will be launching a unique proprietary inhalation technology, intended to greatly improve the cannabis experience. The development allows HEXO to increase its straight edge pre-roll production capacity, accelerating the delivery of the immensely popular Redecan Redees products to include the new TnT cannabis strain series and expanding HEXO’s Original Stash brand to address rising consumer demand. Consumers have reacted positively to the new format and strains, and this expansion supports HEXO’s continued leadership of the Canadian straight edge pre-roll market. The Redecan Redees straight edge pre-roll is HEXO’s premium pre-roll product and Canada’s fastest growing and largest pre-roll in terms of market share. Redees are known as some of the smoothest products on the market and do not have an “after-burn” like many straight edge pre-roll products. Consumers also prefer their ease of use, appealing packaging and convenience over the more common but less consistent commodity cannabis products. Thoughtfully designed with an extra-long filter, tightly packed and offered in a convenient 10-pack, Redecan Redees are the original personal-sized straight edge pre-roll. Redecan Redees straight edge pre-rolls also now feature a unique inhalation technology, developed through comprehensive consumer research and feedback. Incorporating the new proprietary technology allows an enhanced draw and intake, further heightening the consumer experience. HEXO’s flagship Redecan Redees brand is launching several TnT strains throughout the year, including Warlock, Gluberry and Animal Rntz, along with a new 2:1 CBD:THC balanced product, CBD Kush, which offers the benefits of both cannabinoids. The brand will also continue to feature consumer favourites such as the Cold Creek Kush Redees and WappaRedees. HEXO’s Original Stash line will launch its own straight edge pre-rolls, featuring the line’s popular Atomik Sour Haze and Powdered Donuts.
공시 • Jan 28HEXO Corp Wins Complete Dismissal of Putative Québec Shareholder Class ActionHEXO Corp. announced that it has won a complete dismissal of the putative securities class action lawsuit pending before the Québec Superior Court against the Company and its former Chief Executive Officer, filed on November 19, 2019 on behalf of certain primary market and secondary market purchasers of securities of the Company. As previously disclosed, HEXO and its former Chief Executive Officer (“Defendants”) were named in a shareholder class action lawsuit filed in the province of Québec. The lawsuit asserted causes of action for misrepresentations and breaches of disclosure obligations under the Québec Securities Act and the Civil Code of Québec in connection with certain statements contained in HEXO’s prospectus, public documents and public oral statements between April 11, 2018 and March 27, 2020. In a 48-page opinion dated January 23, 2023, the Superior Court of Québec dismissed the Plaintiff’s amended motion in its entirety, with costs. The Court agreed with the Defendants that there was “no reasonable possibility” that the secondary market claim filed under the Québec Securities Act had a reasonable chance of success, or that the Plaintiff had demonstrated an arguable case for a primary market class action or a civil liability class action “for misrepresentation under the general principles of fault in the civil law.” The Plaintiff has a right to appeal.
공시 • Jan 10HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash BrandsHEXO Corp. announced the launch of its new TnT Cannabis strains under the Redecan and Original Stash Brandslabels across Canada. The new strains further expand HEXO’s top-selling product portfolio and are available on retailer shelves now. The launch includes three new products from HEXO’s popular Redecan line and two new strains under the Original Stash Brand. Redecan’s hang-dried and hand-trimmed cannabis features a trailblazing THC range of 23 to 35% and high terpene profiles tailored for creativity, excitement and to help unwind. The new TnT cannabis strains will feature extremely dense buds covered in trichomes: Sex Panther (flower), an Indica hybrid strain, has a powerful effervescent cake flavour. Violet Fog (flower), a purple reign Indica strain, from the Grape Gasoline and Khalifa Mints Strains features robust fruity and sour notes. Animal Rntz (flower), a combination of Canada’s popular Animal Cookie and California’s RNTZ strains, has a fruity tartness along with a sweet and sour aroma, highlighted by astounding levels of limonene and caryophyllene terpenes. HEXO’sMaster Growers have spent the past two years optimizing cannabis genetics and cultivation techniques on their proprietary Indica and Sativa cannabis strains to maximize terpenes and THC percentages for the Canadian market. The new strains added to the Original Stash Brand line-up leverage Canada’s broadest Licensed Producer’s cultivation capabilities and include: Atomik Sour Haze (flower), Sativa strain features amazing fruity and sour notes. Ghost Gelato (flower), an Indica strain, bringing a funk smell reminiscent of old school marijuana.
Reported Earnings • Dec 15First quarter 2023 earnings: EPS and revenues miss analyst expectationsFirst quarter 2023 results: CA$0.094 loss per share (improved from CA$0.47 loss in 1Q 2022). Revenue: CA$35.8m (down 29% from 1Q 2022). Net loss: CA$56.3m (loss narrowed 52% from 1Q 2022). Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Pharmaceuticals industry in the US.
공시 • Dec 07HEXO Corp., Annual General Meeting, Jan 31, 2023HEXO Corp., Annual General Meeting, Jan 31, 2023.
Board Change • Nov 16High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Nov 02Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: CA$2.76 loss per share (further deteriorated from CA$0.90 loss in FY 2021). Revenue: CA$191.1m (up 54% from FY 2021). Net loss: CA$1.07b (loss widened CA$958.8m from FY 2021). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) exceeded analyst estimates by 2.8%. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Pharmaceuticals industry in the US.
Breakeven Date Change • Nov 01No longer forecast to breakevenThe 9 analysts covering HEXO no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$15.5m in 2025. New consensus forecast suggests the company will make a loss of CA$0 in 2025.
Seeking Alpha • Aug 30Hexo to produce Mike Tyson's cannabis brand's products in CanadaHexo (NASDAQ:HEXO) said it signed an exclusive partnership with Mike Tyson's recently formed cannabis company TYSON 2.0. Under the agreement, Hexo will produce TYSON 2.0's products in Canada, including full range of flower, pre-rolls, edibles and vapes. The HEXO-produced lines will launch across Canada in fall 2022, the company said in an Aug. 30 press release. "With their broad product range from flower to straight edge pre-rolls to edibles, the TYSON 2.0 brand fits perfectly into HEXO's market leading portfolio," said Hexo CEO Charlie Bowman. HEXO +4.67% to $0.22 premarket Aug. 30
Seeking Alpha • Aug 17Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatterCanopy Growth (NASDAQ:CGC), Tilray Brands (NASDAQ:TLRY), and other Canadian cannabis licensed producers are markedly higher in Wednesday trading as chatter about the industry on WallStreetBets intensifies. In Wednesday morning trading, Canopy (CGC) is up 11%, Tilray (TLRY) up 4%, Aurora Cannabis (NASDAQ:ACB) up 6%, and HEXO Corp. (NASDAQ:HEXO) up 11%. There is increased discussion about Canadian LPs on WallStreetBets which may account for the increases. Tilray (TLRY) CEO Irwin Simon, in a recent interview with Yahoo Finance, said that the U.S. represents in $100B opportunity in cannabis. That opportunity could become reality if a federal marijuana legalization bill gets signed into law. Check out a recent deep dive into Tilray (TLRY) and whether the stock is a buy at this time.
Seeking Alpha • Jul 28HEXO receives additional 180 calendar day grace period for regaining complianceHEXO (NASDAQ:HEXO) received an extension of 180 calendar days post expiration of initial 180 calendar days period to regain minimum bid price requirement compliance on July 25, 2022 from the Nasdaq Stock Market. The company now has time until Jan.23, 2023 to regain compliance after which the company is likely to receive notification for shares delisting. The current notification has no impact on the listing.
Breakeven Date Change • Jul 21No longer forecast to breakevenThe 9 analysts covering HEXO no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$7.95m in 2024. New consensus forecast suggests the company will make a loss of CA$24.7m in 2024.
Board Change • Jul 21High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Seeking Alpha • Jul 05HEXO wins shareholder approval for note transaction with TilrayCanadian cannabis player HEXO Corp (NASDAQ:HEXO) announced on Tuesday that the company’s shareholders voted in favor of its previously disclosed transaction of convertible notes with its domestic rival Tilray (TLRY). ~87% of votes were in favor of approving certain terms of the deal, the company said following a reconvened special meeting of shareholders today. ~18% of the company’s common shares were represented at the meeting, which was initially scheduled for June 14. However, the meeting was adjourned to provide investors more time to evaluate the previously announced amendments to the transaction. Under the deal anticipated to close in 3Q 2022, Tilray (TLRY) is set to purchase as much as $185M of debt Hexo (HEXO) has issued to funds affiliated with HT Investments.
Seeking Alpha • Apr 28HEXO: Undervalued, But With Certain Dilution RisksHEXO Corp. runs a consumer packaged goods cannabis business model with a leader position in the Canadian market and a production capacity of 150,000 kgs. HEXO has already signed supply agreements with partners overseas, so I would be expecting an increase in international sales growth in the coming years. In my view, economies of scale, more efficient automated technology, and the integration of new acquisitions will likely lead to lower cost per gram.
Breakeven Date Change • Apr 11Forecast to breakeven in 2024The 9 analysts covering HEXO expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 40% per year to 2023. The company is expected to make a profit of CA$7.95m in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule.
Board Change • Apr 01High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Mar 19Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: CA$2.00 loss per share (down from CA$0.17 loss in 2Q 2021). Revenue: CA$52.8m (up 61% from 2Q 2021). Net loss: CA$710.9m (loss widened CA$690.0m from 2Q 2021). Revenue missed analyst estimates by 7.7%. Earnings per share (EPS) exceeded analyst estimates by 2,546%. Over the next year, revenue is forecast to grow 61%, compared to a 17% growth forecast for the industry in the US.
Board Change • Mar 04High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 1 experienced director. No highly experienced directors. Independent Director Vincent Chiara is the most experienced director on the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Jan 01High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Chairman of the Board John Bell was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Dec 16First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2022 results: CA$0.47 loss per share (down from CA$0.035 loss in 1Q 2021). Revenue: CA$50.2m (up 70% from 1Q 2021). Net loss: CA$117.3m (loss widened CA$113.1m from 1Q 2021). Revenue missed analyst estimates by 7.2%. Earnings per share (EPS) exceeded analyst estimates by 358%. Earnings per share (EPS) surpassed analyst estimates by 358%. Over the next year, revenue is forecast to grow 76%, compared to a 15% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has fallen by 61% per year, which means it is performing significantly worse than earnings.
Seeking Alpha • Dec 14HEXO Q1 Earnings: Not A Great Path ForwardHEXO reported weak FQ1 results for the period ending Oct. 31. The addition of the businesses of Redecan and 48North didn't improve the financials or move the company any closer to being cash flow positive. The stock isn't touchable with the senior debt overhang and another restructuring in the works.
Board Change • Dec 03High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. President, CEO & Director Scott Cooper was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 29Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 28Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 27Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 26Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.
Executive Departure • Nov 25Director & Co-Founder Sebastien St-Louis has left the companyDuring their tenure, earnings grew by 87% annually compared to the industry average of 15%. On the 18th of November, Sebastien St-Louis was replaced as CEO by Scott Cooper after 8.2 years in the role. As of September 2021, Sebastien still personally held 1.59m shares (US$2.9m worth at the time). Sebastien is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.29 years.